Tags

Type your tag names separated by a space and hit enter

[Preeclampsia - a disease of pregnant women].
Postepy Biochem 2018; 64(4):232-229PB

Abstract

Preeclampsia, also known as EPH-gestosis, is a pregnancy-specific syndrome. It affects 3-5% of pregnant women and is characterized by edemas, high blood pressure and proteinuria. Moreover, in women with preeclampsia dysfunction of many organs, such as kidney and liver, is diagnosed, while in the case of fetus growth restriction is observed. Preeclampsia, when left untreated, can lead to death. In low-income countries, this disorder is one of the main causes of maternal and child mortality. Preeclampsia predisposes women in later life to cardiovascular diseases. So far, in acute cases of preeclampsia stabilization of the mother and fetus and finally termination of pregnancy at a time optimal for both sides can only be considered. In this work, available literature data concerning the causes of preeclampsia, its symptoms, techniques for diagnosis, methods for prevention and new approaches to treatment were collected.

Authors+Show Affiliations

Pracownia Białek Wiążących Wapń, Instytut Biologii Doświadczalnej im. M. Nenckiego PAN, Warszawa.Pracownia Białek Wiążących Wapń, Instytut Biologii Doświadczalnej im. M. Nenckiego PAN, Warszawa.

Pub Type(s)

Journal Article
Review

Language

pol

PubMed ID

30656917

Citation

Filipek, Anna, and Ewelina Jurewicz. "[Preeclampsia - a Disease of Pregnant Women]." Postepy Biochemii, vol. 64, no. 4, 2018, pp. 232-229.
Filipek A, Jurewicz E. [Preeclampsia - a disease of pregnant women]. Postepy Biochem. 2018;64(4):232-229.
Filipek, A., & Jurewicz, E. (2018). [Preeclampsia - a disease of pregnant women]. Postepy Biochemii, 64(4), pp. 232-229. doi:10.18388/pb.2018_146.
Filipek A, Jurewicz E. [Preeclampsia - a Disease of Pregnant Women]. Postepy Biochem. 2018 Dec 29;64(4):232-229. PubMed PMID: 30656917.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Preeclampsia - a disease of pregnant women]. AU - Filipek,Anna, AU - Jurewicz,Ewelina, PY - 2018/05/22/received PY - 2018/06/04/accepted PY - 2019/1/19/entrez PY - 2019/1/19/pubmed PY - 2019/6/15/medline SP - 232 EP - 229 JF - Postepy biochemii JO - Postepy Biochem. VL - 64 IS - 4 N2 - Preeclampsia, also known as EPH-gestosis, is a pregnancy-specific syndrome. It affects 3-5% of pregnant women and is characterized by edemas, high blood pressure and proteinuria. Moreover, in women with preeclampsia dysfunction of many organs, such as kidney and liver, is diagnosed, while in the case of fetus growth restriction is observed. Preeclampsia, when left untreated, can lead to death. In low-income countries, this disorder is one of the main causes of maternal and child mortality. Preeclampsia predisposes women in later life to cardiovascular diseases. So far, in acute cases of preeclampsia stabilization of the mother and fetus and finally termination of pregnancy at a time optimal for both sides can only be considered. In this work, available literature data concerning the causes of preeclampsia, its symptoms, techniques for diagnosis, methods for prevention and new approaches to treatment were collected. SN - 0032-5422 UR - https://www.unboundmedicine.com/medline/citation/30656917/[Preeclampsia_-_a_disease_of_pregnant_women] L2 - https://postepybiochemii.ptbioch.edu.pl/index.php/PB/article/view/146 DB - PRIME DP - Unbound Medicine ER -